External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society

被引:58
|
作者
Kiess, Ana P. [1 ]
Agrawal, Nishant [2 ]
Brierley, James D. [3 ]
Duvvuri, Umamaheswar [4 ,5 ]
Ferris, Robert L. [4 ]
Genden, Eric [6 ]
Wong, Richard J. [7 ]
Tuttle, R. Michael [8 ]
Lee, Nancy Y. [9 ]
Randolph, Gregory W. [9 ,10 ]
机构
[1] Johns Hopkins Med Inst, Dept Radiat Oncol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA
[3] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[4] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA
[5] VA Pittsburgh Hlth Syst, Pittsburgh, PA USA
[6] Mt Sinai Hosp, Dept Otolaryngol, New York, NY 10029 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, 1275 York Ave, New York, NY 10021 USA
[8] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA
[9] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
[10] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otolaryngol, Boston, MA USA
关键词
radiotherapy; radiation; thyroid cancer; papillary; follicular; PERCUTANEOUS ETHANOL INJECTION; 2ND PRIMARY MALIGNANCIES; RADIOACTIVE IODINE; PROGNOSTIC-FACTORS; RADIATION-THERAPY; RADIOFREQUENCY ABLATION; REMNANT ABLATION; PAPILLARY; CARCINOMA; RECURRENT;
D O I
10.1002/hed.24357
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The use of external-beam radiotherapy (EBRT) in differentiated thyroid cancer (DTC) is debated because of a lack of prospective clinical data, but recent retrospective studies have reported benefits in selected patients. The Endocrine Surgery Committee of the American Head and Neck Society provides 4 recommendations regarding EBRT for locoregional control in DTC, based on review of literature and expert opinion of the authors. (1) EBRT is recommended for patients with gross residual or unresectable locoregional disease, except for patients <45 years old with limited gross disease that is radioactive iodine (RAI)-avid. (2) EBRT should not be routinely used as adjuvant therapy after complete resection of gross disease. (3) After complete resection, EBRT may be considered in select patients >45 years old with high likelihood of microscopic residual disease and low likelihood of responding to RAI. (4) Cervical lymph node involvement alone should not be an indication for adjuvant EBRT. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:493 / 498
页数:6
相关论文
共 50 条
  • [1] Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer
    Groen, Andries H.
    van Dijk, Deborah
    Sluiter, Wim
    Links, Thera P.
    Bijl, Hendrik P.
    Plukker, John T. M.
    [J]. EUROPEAN THYROID JOURNAL, 2022, 11 (01)
  • [2] Paragangliomas of the head and neck treated with external-beam radiotherapy
    Hinerman, R.
    Morris, C. G.
    Mendenhall, W. M.
    Amdur, R. J.
    Kirwan, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S434 - S434
  • [3] External Beam Radiotherapy for Differentiated Thyroid Cancer
    Powell, C.
    Newbold, K.
    Harrington, K. J.
    Bhide, S. A.
    Nutting, C. M.
    [J]. CLINICAL ONCOLOGY, 2010, 22 (06) : 456 - 463
  • [4] External beam radiotherapy for differentiated thyroid cancer
    Meadows, KM
    Amdur, RJ
    Morris, CG
    Villaret, DB
    Mazzaferri, EL
    Mendenhall, WM
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2006, 27 (01) : 24 - 28
  • [5] Management of invasive well-differentiated thyroid cancer: An American Head and Neck Society Consensus Statement AHNS Consensus Statement
    Shindo, Maisie L.
    Caruana, Salvatore M.
    Kandil, Emad
    McCaffrey, Judith C.
    Orloff, Lisa A.
    Porterfield, John R.
    Shaha, Ashok
    Shin, Jennifer
    Terris, David
    Randolph, Gregory
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (10): : 1379 - 1390
  • [6] External-beam radiation therapy in the treatment of differentiated thyroid cancer
    Brierley, JD
    Tsang, RW
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1999, 16 (01): : 42 - 49
  • [7] External beam radiotherapy in the management of differentiated thyroid cancer
    Ford, D
    Giridharan, S
    McConkey, C
    Hartley, A
    Brammer, C
    Watkinson, JC
    Glaholm, J
    [J]. CLINICAL ONCOLOGY, 2003, 15 (06) : 337 - 341
  • [8] Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer
    Kenji Makita
    Yasushi Hamamoto
    Shintaro Tsuruoka
    Noriko Takata
    Yusuke Urashima
    Masao Miyagawa
    Teruhito Mochizuki
    [J]. International Journal of Clinical Oncology, 2020, 25 : 691 - 697
  • [9] Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer
    Makita, Kenji
    Hamamoto, Yasushi
    Tsuruoka, Shintaro
    Takata, Noriko
    Urashima, Yusuke
    Miyagawa, Masao
    Mochizuki, Teruhito
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (04) : 691 - 697
  • [10] External-beam radiotherapy for pain control
    Rades, D.
    [J]. ONKOLOGE, 2009, 15 (07): : 669 - 679